SR-9009 (Stenabolic) Research Reference at Chemyo
This is the Chemyo research reference for SR-9009 Stenabolic: what the compound is, its molecular identity, the formats in stock and the published batch testing. SR-9009 is supplied for research use only; nothing on this page is dosing, administration or clinical guidance.
What is SR-9009?
SR-9009, sold as Stenabolic, is a synthetic agonist of the nuclear receptors REV-ERBα and REV-ERBβ, which help regulate the circadian clock and the expression of metabolic genes. It was developed in Thomas Burris’s laboratory at Scripps Research, and a 2012 paper in Nature described its effects on circadian behaviour and metabolism in mice.
SR-9009 has poor oral bioavailability in published animal work, and a 2019 study reported that some of its cellular effects persist even when REV-ERB is absent, which complicates how earlier results are interpreted. It remains a pre-clinical tool compound with no human trials.
Molecular identity
| CAS number | 1379686-30-2 |
| Molecular formula | C20H24ClN3O4S |
| Molar mass | 437.94 g/mol |
| Synonyms | Stenabolic, SR9009, SR 9009 |
| Research class | REV-ERB agonist research compound |
Where to buy SR-9009 for research
Searches for buy Stenabolic turn up many listings with no batch data. At Chemyo every lot of SR-9009 below has its identity, purity and, for solutions, concentration results published, so you can check the material before you order it.
- SR9009 Solution 10mg/ml – 50ml
Liquid solution · batch FTIR and HPLC report plus concentration assay
- SR9009 Powder – 1g
Research powder · batch FTIR and HPLC report
Browse all SARM solutions, research powders and value packs.
Quality control
Every batch is independently tested: FTIR for identity, HPLC for purity and, for solutions, a separate concentration assay. Reports are listed by batch number in the Chemyo lab reports library, and our quality control process explains each step. To check a certificate yourself, see how to read a SARM COA.
SR-9009 FAQ
What is the difference between SR-9009 and SR-9011?
Both are REV-ERB agonists from the same Scripps programme and were studied side by side. They differ in structure and pharmacokinetics; SR-9009 is the better known of the two.
Is SR-9009 a SARM?
No. It targets the REV-ERB nuclear receptors involved in circadian rhythm, not the androgen receptor.
Has SR-9009 been tested in humans?
No clinical trials have been published. All available data come from cell and animal studies.
Which SR-9009 formats are available?
Chemyo stocks a 10 mg/ml SR-9009 solution in 50 ml and a 1 g powder.
Related research references
Compliance: all Chemyo products are supplied for laboratory research only and are not for human or veterinary use. Read the terms and conditions before ordering.